0.2695
5.27%
-0.015
アフターアワーズ:
.279
0.0095
+3.53%
Qualigen Therapeutics Inc (QLGN) 最新ニュース
Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
GlobeNewswire Inc.
Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting
GlobeNewswire Inc.
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Benzinga
Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023
GlobeNewswire Inc.
大文字化:
|
ボリューム (24 時間):